Ventricular pacing with premature excitation for treatment of hypertensive-cardiac hypertrophy with cavity-obliteration

Keyphrases

• Ventricular Pacing 100%
• Obliteration 100%
• Hypertensive Cardiac Hypertrophy 100%
• Exercise Capacity 66%
• Clinical Activity 66%
• Activities of Daily Living 66%
• Ejection 66%
• Pre-activation 66%
• Clinical Symptoms 66%
• Off Periods 66%
• Dual-chamber Pacing 66%
• Maximal Oxygen Uptake 33%
• Pharmacological Treatment 33%
• Cardiac Output 33%
• Stroke Volume 33%
• Metabolic 33%
• 1-year Follow-up 33%
• Quality of Life Assessment 33%
• Dyspnea 33%
• Quality of Testing 33%
• Left Ventricular Hypertrophy 33%
• Echocardiographic 33%
• Crossover Design 33%
• Dobutamine 33%
• Exertional Dyspnea 33%
• Basal Values 33%
• Exercise Duration 33%
• Randomized Double-blind 33%
• Exercise Test 33%
• Dual-chamber Pacemaker 33%
• Cardiac Reserve 33%
• Dobutamine Stress 33%
• Exertional 33%
• Exercise Tolerance 33%
• Supranormal 33%

Medicine and Dentistry

• Exercise 100%
• Prematurity 100%
• Dobutamine 100%
• Ventricular Hypertrophy 100%
• Dyspnea 100%
• Drug Therapy 50%
• Oxygen Consumption 50%
• Stroke Volume 50%
• Heart Output 50%
• Exercise Test 50%
• Quality of Life Assessment 50%
• Left Ventricular Hypertrophy 50%
• Exercise Tolerance 50%

Pharmacology, Toxicology and Pharmaceutical Science

• Prematurity 100%
• Dyspnea 100%
• Heart Ventricle Hypertrophy 100%
• Dobutamine 100%
• Cerebrovascular Accident 50%
• Syndrome 50%
• Heart Left Ventricle Hypertrophy 50%